Epigenetics Market to reach USD 66 Billion by 2032, growing at a CAGR of 17.7%
The epigenetics market is mainly driven by the increasing government funding for research and development and rising advancements in precision medicine. According to the National Institutes of Health (NIH), federal funding for epigenetic research has surged to $1.2 billion in 2023, reflecting the growing recognition of epigenetics\' potential in understanding complex diseases and developing targeted therapies.